Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optical-Resolution Photoacoustic Microscopy-Based Virtual Staining: A Wavelet-Enhanced Contrastive Translation Approach With Structure Preservation.

Journal of biophotonics·2026
Same author

Aurka-Bhlhe41 axis prevents premature aging-like microglial dysfunction and promotes remyelination.

Nature communications·2026
Same author

Evolution of AR and Non-AR Alterations in ctDNA of Patients with Metastatic Prostate Cancer Treated in the Phase III Alliance A031201 Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Letter: Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment.

The Journal of urology·2025
Same author

Digital twins as global learning health and disease models for preventive and personalized medicine.

Genome medicine·2025
Same author

Multiomics biomarkers were not superior to clinical variables for pan-cancer screening.

Communications medicine·2024

Related Experiment Video

Updated: May 8, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K

Combining Spatial Transcriptomics, Pseudotime, and Machine Learning Enables Discovery of Biomarkers for Prostate

Martin Smelik1, Daniel Diaz-Roncero Gonzalez1, Xiaojing An2

  • 1Division of ENT Diseases, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden.

Cancer Research
|April 28, 2025
PubMed
Summary
This summary is machine-generated.

Developing reliable biomarkers for early cancer diagnosis is difficult. This study identifies novel prostate cancer biomarkers using spatial transcriptomics and pseudotime analysis, achieving high diagnostic accuracy in urine samples.

More Related Videos

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection
09:19

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection

Published on: July 6, 2022

4.8K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.7K

Related Experiment Videos

Last Updated: May 8, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K
Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection
09:19

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection

Published on: July 6, 2022

4.8K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.7K

Area of Science:

  • Oncology
  • Genomics
  • Biomarker Discovery

Background:

  • Early cancer diagnosis relies on reliable biomarkers, which are challenging to identify due to tumor complexity and inter-patient variability.
  • Current methods struggle with the intricate gene interaction networks within tumors and across different patients.

Purpose of the Study:

  • To identify reliable biomarkers for early prostate cancer detection measurable by routine clinical methods.
  • To leverage spatial transcriptomics and pseudotime analysis to model malignant transformation and discover novel biomarkers.

Main Methods:

  • Spatial transcriptomics data from three prostate cancer studies were used to construct pseudotime models of malignant transformation.
  • Genes correlated with malignant transformation were identified and validated as candidate biomarkers.
  • Machine learning models were applied to mRNA, immunohistochemistry, proteomics, serum, tissue, and urine data from over 2,000 patients.

Main Results:

  • Identified genes associated with cancer grade, copy number aberrations, hallmark pathways, and drug targets.
  • Candidate biomarkers were found across multiple data types (mRNA, IHC, proteomics) and sample sources (serum, tissue, urine).
  • Urine-based biomarkers achieved an Area Under the Curve (AUC) of 0.92 for prostate cancer detection and correlated with cancer grade.

Conclusions:

  • The combination of spatial transcriptomics, pseudotime, and machine learning shows significant potential for prostate cancer diagnosis.
  • Novel biomarkers detected in urine offer a promising, non-invasive approach for early cancer detection.
  • Further validation in prospective studies is warranted to confirm the clinical utility of these findings.